Trial Profile
Study of BAY 94-9027 in previously untreated patients with haemophilia A.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2015
Price :
$35
*
At a glance
- Drugs Damoctocog alfa pegol (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Sponsors Bayer HealthCare
- 03 Apr 2014 New trial record